Press release
Emergency Contraceptive Pills Market valuation of US$ 1230 million throughout the forecast period of 2017-2022
Research Solution Insights presents professional and in-depth study of "Emergency Contraceptive Pills Market: Global Industry Analysis, size, sales and Forecast by 2022".An emergency contraception is a birth control way to avoid pregnancy in women. The emergency contraception pills most probably avoid pregnancy, in the same manner, the same as standard birth control pills. The emergency contraceptive pills offered in the market are uneven and have the related purpose. Nevertheless, the efficiency of these pills, in addition to leaning towards the pills with slightest side effects, fuels the growth of the worldwide market. On the other hand, the sales of the emergency pills are likely to be hampered because of unsettled side effects which include a time limitation for intake, muscle spasms, heavy vomiting and nausea.
Request For Report Sample: https://www.researchsolutioninsights.com/report/sample/230160-Emergency-Contraceptive-Pills-Market
The worldwide sales of the emergency contraceptive pills are projected for a sluggish growth, recording a market valuation of US$ 1230 million throughout the forecast period of 2017-2022. The worldwide market is expected to record a CAGR below 3% in terms of value during the five years forecast period.
Market segmentation
Analysis by product type
On the basis of product type, the market is further fragmented into progesterone pills, combination pills, estrogen pills and other products. Amongst these, the combination pills are anticipated to evolve as the highest productive fragment in the worldwide market as a result of eliminating the possibility of ectopic pregnancy. The combination pills in the global market are likely to contribute around 40% of revenue shares in 2017. However, the sales of the estrogen pills are likely to lose hold of the market by registering a CAGR of 1.5% of revenue shares along with progesterone pills.
Analysis by sales channel
On the basis of sales channel, the market is sub-divided into hospital pharmacies, drug store/pharmacies, online trader and other channels. The drug stores/pharmacies and hospital pharmacies are undeniably the two leading sales channels by accounting for over 70% of the revenue shares at the beginning of the forecast period. The Online sales channel is also likely to witness a considerable decline by capturing less than US$ 160 million in worldwide revenue market by 2022 end.
Analysis by region
The overall market is segmented into five key regions namely Europe, Latin America, North America, MEA and APAC. Among these regions, North America is expected to be the biggest market. However, the European and the Asia Pacific excluding Japan region are likely to lose their hold in the worldwide market.
Request Report Discount: https://www.researchsolutioninsights.com/report/discount/230160-Emergency-Contraceptive-Pills-Market
Key Market Players
The leading companies in the worldwide emergency contraceptive pills market include
Richter Gedeon Nyrt
Bayer AG
Piramal Enterprises Limited
Teva Pharmaceutical Industries Ltd.
Mankind Pharma Ltd.
Cooper Pharma
Lupin Limited
HRA Pharma
Zhejiang Xianju Pharmaceutical Co
Pfizer Inc.
About Us :
Research Solution Insights is a U.S. based market research and consulting company. We are the best destination for your research and analytical solutions; simply because our primary and secondary sources of information are adroit to give one stop solutions.Company provides syndicated research reports, customized research reports, and consulting services. We offer the comprehensive market research solution for all the industries by performing the in-depth study of industry trends, verticals globally. We believe in building an eternal bond with our customers through providing them inclusive research study both customized and syndicated based on their specific requirements.
Contact Us:
Research Solution Insights (RSI)
42 Joseph Street
Port carling P0B 1J0
Muskoka, Ontario1
Phone - +44-1618508625
Website: https://www.researchsolutioninsights.com/
Email: sales@researchsolutioninsights.com
Follow me on: https://futureresearchreports.blogspot.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emergency Contraceptive Pills Market valuation of US$ 1230 million throughout the forecast period of 2017-2022 here
News-ID: 1621794 • Views: β¦
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M β¦
πππ, πππ° πππ«π¬ππ²- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDΒ 22.32Β Billion by 2024. The valuation is expected to reach USDΒ 47.79Β Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of theβ¦
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi β¦
πππ, πππ° πππ«π¬ππ²- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingβ¦
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi β¦
πππ, πππ° πππ«π¬ππ²- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asβ¦
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh β¦
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theβ¦
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, β¦
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoringβ¦
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 β¦
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about theβ¦